Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response

Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response

US Patent 10653771 · Granted May 19, 2020

Estimated economic value: $1,413,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Multivalent pneumococcal vaccines2025
Pneumococcal dosing regimen2025
Multivalent pneumococcal vaccines2023
Immunogenic compositions2023
Process for preparing pneumococcal polysaccharide-protein conjugates2021
Pneumococcal dosing regimen2021
Antigen screening system2021
Multivalent pneumococcal vaccines2021
Treatment methods2020
Process for preparing pneumococcal polysaccharide-protein conjugates2020
Process for preparing pneumococcal polysaccharide-protein conjugates2020
Antigen screening system2020